News

RSS feed

Europe’s drugs regulator has for the first time recommended a gene therapy for approval

A gene therapy medicine was backed for the first time by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). In the prestigious British review Nature, Fulvio Mavilio, Scientific Director of Genethon, is delighted about this news which is an encouragement, for Genethons projects and for the Gene Therapy area as a … [Read more]

Summary of activities 2011 Genethon

Genethon publishes its Summary of activities 2011. You will find the scientific milestones, skills, funding sources, key figures, and a reminder of mission and governance of Genethon.  To access the document (PDF in FRENCH – 3 pages – 773 Ko)

L’Etudiant

Portrait of a young research engineer working in gene therapy at Genethon

Genethon Lecture Series: 2012, June 18th

 Monday June 18th, 2012: « New AAV gene therapy strategies for spinal muscular atrophy » Doctor Martine Barkats (Chercheur CR1 Inserm, Chef de groupe “Transfert de gène dans le système nerveux central et maladies du motoneurone”, Institut de Myologie)

Genethon Lecture Series: 2012, June 12th

 Tuesday June 12th, 2012: «The promises and challenges of gene therapy based strategies for inherited retinal diseases» Doctor Enrico Maria Surace, D.V.M. (TIGEM, Telethon Institute of Genetics and Medicine, Napoli, Italy)

Genethon Lecture Series: 2012, March 12th

 Wednesday March 12th, 2012 : “Lentiviral vectors as vaccinnes” Professor Mary Collins (Faculty of Life Sciences, University College London, UK)

Industrie Pharma

Gene therapy: encouraging phase I results for the gamma sarcoglycanopathy

Industrie Pharma

Fulvio Mavilio, Scientific Director

La revue du Praticien

Genethon: laboratory of theTelethon

(Reporter: Catherine Holué)

La Recherche

Gene therapy on an industrial scale